i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands
-
Published Date:
Feb 2020
-
Source:Emerg Infect Dis. 26(2):238-246
-
Language:English
-
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:In the aftermath of a large Q fever (QF) epidemic in the Netherlands during 2007-2010, new chronic QF (CQF) patients continue to be detected. We developed a health-economic decision model to evaluate the cost-effectiveness of a 1-time screening program for CQF 7 years after the epidemic. The model was parameterized with spatial data on QF notifications for the Netherlands, prevalence data from targeted screening studies, and clinical data from the national QF database. The cost-effectiveness of screening varied substantially among subpopulations and geographic areas. Screening that focused on cardiovascular risk patients in areas with high QF incidence during the epidemic ranged from cost-saving to €31,373 per quality-adjusted life year gained, depending on the method to estimate the prevalence of CQF. The cost per quality-adjusted life year of mass screening of all older adults was €70,000 in the most optimistic scenario.
-
Subject:
-
Pubmed ID:31961297
-
Pubmed Central ID:PMC6986831
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
image/gif image/jpeg image/gif image/jpeg image/gif image/jpeg application/pdf text/xml
No Related Documents.